These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3968199)

  • 1. Monoclonal and specific polyclonal antibodies for immunoassay of Clostridium difficile toxin A.
    Lyerly DM; Phelps CJ; Wilkins TD
    J Clin Microbiol; 1985 Jan; 21(1):12-4. PubMed ID: 3968199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies specific for Clostridium difficile toxin B and their use in immunoassays.
    Müller F; Stiegler C; Hadding U
    J Clin Microbiol; 1992 Jun; 30(6):1544-50. PubMed ID: 1378062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and preliminary application of monoclonal antibodies to the receptor binding region of Clostridium difficile toxin B.
    Chen W; Liu WE; Li YM; Luo S; Zhong YM
    Mol Med Rep; 2015 Nov; 12(5):7712-20. PubMed ID: 26459027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an ELISA kit using monoclonal antibody to Clostridium difficile toxin A.
    Fu SW; Zhang YL; Zhou DY
    World J Gastroenterol; 2004 Sep; 10(18):2747-9. PubMed ID: 15309733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of bacterial isolation, cytotoxicity assay, and counterimmunoelectrophoresis for the detection of Clostridium difficile and its toxin.
    Jarvis W; Nunez-Montiel O; Thompson F; Dowell V; Towns M; Morris G; Hill E
    J Infect Dis; 1983 Apr; 147(4):778. PubMed ID: 6842010
    [No Abstract]   [Full Text] [Related]  

  • 6. Production and release of toxins A and B by Clostridium difficile.
    Ketley JM; Haslam SC; Mitchell TJ; Stephen J; Candy DC; Burdon DW
    J Med Microbiol; 1984 Dec; 18(3):385-91. PubMed ID: 6389875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant single-chain variable fragment antibodies directed against Clostridium difficile toxin B produced by use of an optimized phage display system.
    Deng XK; Nesbit LA; Morrow KJ
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):587-95. PubMed ID: 12853390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of latex agglutination test for Clostridium difficile toxin A (D-1) and differentiation between C difficile toxins A and B and latex reactive protein.
    Borriello SP; Barclay FE; Reed PJ; Welch AR; Brown JD; Burdon DW
    J Clin Pathol; 1987 May; 40(5):573-80. PubMed ID: 3108333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latex agglutination test for detection of Clostridium difficile toxin in stool samples.
    Shahrabadi MS; Bryan LE; Gaffney D; Coderre SE; Gordon R; Pai CH
    J Clin Microbiol; 1984 Sep; 20(3):339-41. PubMed ID: 6490824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a commercially available latex immunoagglutination test kit for detection of Clostridium difficile D-1 toxin.
    Kamiya S; Nakamura S; Yamakawa K; Nishida S
    Microbiol Immunol; 1986; 30(2):177-81. PubMed ID: 3086678
    [No Abstract]   [Full Text] [Related]  

  • 11. Laboratory diagnosis of Clostridium difficile-associated gastrointestinal disease: comparison of a monoclonal antibody enzyme immunoassay for toxins A and B with a monoclonal antibody enzyme immunoassay for toxin A only and two cytotoxicity assays.
    Doern GV; Coughlin RT; Wu L
    J Clin Microbiol; 1992 Aug; 30(8):2042-6. PubMed ID: 1500512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination.
    Staneck JL; Weckbach LS; Allen SD; Siders JA; Gilligan PH; Coppitt G; Kraft JA; Willis DH
    J Clin Microbiol; 1996 Nov; 34(11):2718-21. PubMed ID: 8897171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme-linked immunosorbent assay (ELISA) for antibodies to Clostridium difficile toxins in patients with pseudomembranous colitis and antibiotic-associated diarrhoea.
    Aronsson B; Granström M; Möllby R; Nord CE
    J Immunol Methods; 1983 Jun; 60(3):341-50. PubMed ID: 6854035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-linked immunosorbent assay for Clostridium difficile toxin A.
    Lyerly DM; Sullivan NM; Wilkins TD
    J Clin Microbiol; 1983 Jan; 17(1):72-8. PubMed ID: 6338036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations in the laboratory diagnosis of antibiotic-associated gastroenteritis.
    Ryan RW
    Diagn Microbiol Infect Dis; 1986 Mar; 4(3 Suppl):79S-86S. PubMed ID: 3516548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Clostridium difficile toxin A by reversed passive latex agglutination.
    Toma C; Nakamura S; Kamiya S; Nakasone N; Iwanaga M
    Microbiol Immunol; 1999; 43(8):737-42. PubMed ID: 10524790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile.
    Banno Y; Kobayashi T; Kono H; Watanabe K; Ueno K; Nozawa Y
    Rev Infect Dis; 1984; 6 Suppl 1():S11-20. PubMed ID: 6426016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of incidence of Clostridium difficile infection in Canadian hospitals and diagnostic approaches.
    Alfa MJ; Du T; Beda G
    J Clin Microbiol; 1998 Jul; 36(7):2076-80. PubMed ID: 9650966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commercial latex agglutination test for detection of Clostridium difficile-associated diarrhea.
    Kelly MT; Champagne SG; Sherlock CH; Noble MA; Freeman HJ; Smith JA
    J Clin Microbiol; 1987 Jul; 25(7):1244-7. PubMed ID: 3611316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the premier toxin A and B assay and the TOX A/B II assay for diagnosis of Clostridium difficile infection.
    Novak-Weekley SM; Hollingsworth MH
    Clin Vaccine Immunol; 2008 Mar; 15(3):575-8. PubMed ID: 18175802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.